111.43
전일 마감가:
$113.52
열려 있는:
$113.83
하루 거래량:
635.94K
Relative Volume:
0.77
시가총액:
$6.26B
수익:
$633.51M
순이익/손실:
$-8.10M
주가수익비율:
-359.45
EPS:
-0.31
순현금흐름:
$131.26M
1주 성능:
-6.29%
1개월 성능:
-13.32%
6개월 성능:
-28.59%
1년 성능:
-33.19%
Repligen Corp Stock (RGEN) Company Profile
명칭
Repligen Corp
전화
(781) 449-9560
주소
41 SEYON STREET, WALTHAM, MA
RGEN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
RGEN
Repligen Corp
|
111.43 | 6.30B | 633.51M | -8.10M | 131.26M | -0.31 |
![]()
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 21.39B | 1.59B | 2.55B | 5.56 |
![]()
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-22 | 재개 | Stephens | Overweight |
2025-06-24 | 개시 | Barclays | Overweight |
2025-04-29 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2025-03-18 | 개시 | Evercore ISI | In-line |
2025-02-10 | 개시 | TD Cowen | Buy |
2024-12-17 | 개시 | Canaccord Genuity | Hold |
2024-11-14 | 개시 | Wolfe Research | Peer Perform |
2024-08-28 | 개시 | Wells Fargo | Overweight |
2024-06-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
2024-06-18 | 개시 | Guggenheim | Neutral |
2023-12-04 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2023-07-20 | 개시 | Wells Fargo | Overweight |
2023-07-05 | 재개 | JP Morgan | Overweight |
2023-03-28 | 개시 | The Benchmark Company | Buy |
2022-12-14 | 개시 | Deutsche Bank | Hold |
2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
2022-07-20 | 개시 | UBS | Buy |
2021-10-14 | 개시 | Exane BNP Paribas | Outperform |
2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
2020-08-24 | 재확인 | H.C. Wainwright | Buy |
2020-06-30 | 재확인 | H.C. Wainwright | Buy |
2020-05-07 | 재확인 | H.C. Wainwright | Buy |
2020-03-23 | 재확인 | H.C. Wainwright | Buy |
2019-11-15 | 개시 | Stifel | Buy |
2019-11-01 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
2019-10-15 | 개시 | SVB Leerink | Outperform |
2019-08-28 | 재확인 | First Analysis Sec | Outperform |
2019-08-23 | 재개 | Stephens | Overweight |
2019-07-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2018-12-17 | 업그레이드 | CL King | Neutral → Buy |
2018-11-12 | 다운그레이드 | CL King | Buy → Neutral |
2018-09-26 | 개시 | H.C. Wainwright | Neutral |
2017-12-08 | 개시 | Citigroup | Buy |
2017-12-05 | 개시 | JP Morgan | Overweight |
2017-11-13 | 개시 | CL King | Buy |
2017-10-02 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
2017-07-21 | 개시 | William Blair | Outperform |
2017-02-13 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
Repligen Corp 주식(RGEN)의 최신 뉴스
Will Repligen Corporation rebound enough to break evenSecure Entry Point Finder with Analysis - Newser
Repligen Corporation stock prediction for this weekFree Secure Return Focused Investment Plan - Newser
Volatility clustering patterns for Repligen CorporationBuy Signal System Based on Price Action - Newser
Will Repligen Corporation benefit from macro trendsFree Daily Stock Market Swing Alerts - Newser
How Repligen Corporation stock performs during market volatilityAutomated AI Forecast with Trading Alerts - Newser
Exit strategy if you’re trapped in Repligen CorporationSafe Entry Zone Based on Chart Analysis - Newser
Sector ETF performance correlation with Repligen CorporationPattern Recognition Tool for ROI Investors - Newser
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight - GuruFocus
Live market analysis of Repligen CorporationDaily Entry Opportunity Forecasting Tool - Newser
REPLIGEN CORP SEC 10-Q Report - TradingView
Pattern recognition hints at Repligen Corporation upsideFree Fast Gaining Stock Screener Report - Newser
Long term hold vs stop loss in Repligen CorporationFree Expert Verified Stock Trade Ideas - Newser
Repligen (NASDAQ:RGEN) Investors Are Sitting on a Loss of 53% If They Invested Three Years Ago - 富途牛牛
Visual analytics tools that track Repligen Corporation performanceInvestment Roadmap for High Potential Stocks - Newser
Fund Update: GENEVA CAPITAL MANAGEMENT LLC added 343,991 shares of REPLIGEN ($RGEN) to their portfolio - Quiver Quantitative
Why Repligen Corporation stock attracts strong analyst attentionSmart Chart Forecasting with AI Algorithms - Newser
Can machine learning forecast Repligen Corporation recoveryReversal Signal Prediction Based on Volume - Newser
What Fibonacci levels say about Repligen Corporation reboundFree Access to Smart Investment Tips - Newser
Geneva Capital Management LLC Buys 7,958 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Why is Repligen Corporation stock attracting strong analyst attentionUnlock exclusive trading strategies for gains - Jammu Links News
Can Repligen Corporation recover in the next quarterBuy Signal Forecast With Short-Term Data - Newser
William Blair Analysts Raise Earnings Estimates for Repligen - Defense World
Pacer Advisors Inc. Cuts Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by Nicolet Advisory Services LLC - Defense World
Blueshift Asset Management LLC Takes $458,000 Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
TD Asset Management Inc Has $6.51 Million Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Evaluating Repligen Corporation with trendline analysisWatchlist Generator With Real-Time Entry - Newser
Q3 Earnings Forecast for Repligen Issued By Leerink Partnrs - Defense World
XTX Topco Ltd Buys 3,295 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Wealthquest Corp Takes Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Royal Bank Of Canada Raises Repligen (NASDAQ:RGEN) Price Target to $204.00 - Defense World
Harvest Fund Management Co. Ltd Invests $132,000 in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Stock Outlook: Risk Skewed To The Downside Through 2026 - Benzinga
Repligen (RGEN) Partners with Novasign to Enhance Filtration Systems - GuruFocus
Repligen Corporation (NASDAQ:RGEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Repligen partners with Novasign to enhance bioprocessing systems - Investing.com
Repligen partners with Novasign to enhance bioprocessing systems By Investing.com - Investing.com Canada
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization - Yahoo Finance
Repligen Corporation (NASDAQ:RGEN) Shares Sold by Norden Group LLC - Defense World
Repligen Corporation (NASDAQ:RGEN) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Repligen Corporation stock outlook for YEARFast Movement Forecast for Trading Success - Newser
Repligen Corporation Reports Strong Q2 2025 Growth - The Globe and Mail
Can trapped investors hope for a rebound in Repligen CorporationIntraday Strategy with Real Time Monitoring - Newser
What candlestick patterns are forming on Repligen CorporationFree Real Time Stock Movement Analysis - Newser
Repligen Corp Reports Strong Revenue Growth Amid Market Challenges - AInvest
Repligen stock rating reiterated at Overweight by KeyBanc on bioprocessing growth - Investing.com Canada
Thornburg Investment Management Inc. Sells 1,646 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
North Star Asset Management Inc. Sells 334 Shares of Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corp (RGEN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Investing.com Canada
Repligen: Q2 Earnings Snapshot - Greenwich Time
Repligen Corporation Forms Bullish Flag — Upside AheadTriple Digit Return Stock Predictions Released - metal.it
Repligen Corp (RGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):